HONG KONG, April 29, 2025 /PRNewswire/ -- Dalton Venture CEO Summit 2025 , jointly hosted by Dalton Venture and Hong Kong Science and Technology Parks Corporation (HKSTP), successfully concluded at Hong Kong Science Park. The summit brought together over 100 distinguished guests, including government officials, leading scholars, entrepreneurs, and investors from Mainland China, Hong Kong, and beyond, to explore new global opportunities in life sciences innovation.
The event gathered more than 60 entrepreneurs from Dalton Venture's portfolio companies across cutting-edge sectors such as cell and gene therapy, ophthalmology, AI in healthcare, embodied AI, bio-3D-printing, and cardiovascular technologies.
Uniting Industry, Research, and Capital to Accelerate Globalization
Founding Managing Partner Sun Qi highlighted Hong Kong's unique advantages as an East-West bridge, with world-class research infrastructure and capital markets. "Dalton Venture sees Hong Kong not only as a gateway to the world but as a convergence point for technology, capital, industry, and vision," as he said.
Ms. Cheong Man Lei, Lillian, JP, Deputy Secretary for Innovation, Technology and Industry of the Hong Kong SAR Government, delivered a video keynote address. She emphasized Hong Kong's commitment to becoming an international innovation and technology hub, citing initiatives like the HK$10 billion Research, Academic and Industry Sectors One-plus Scheme. She warmly welcomed more Mainland Chinese enterprises to leverage Hong Kong's platform for international expansion.
Hong Kong Science Park as a Launchpad for Life Sciences Innovation
Ms. Gracie Ng, Chief of Staff and Acting Chief Corporate Development Officer of HKSTP, also extended a warm welcome. She highlighted HKSTP's role in cultivating a vibrant life sciences ecosystem through research support, incubation services, and funding channels, including its HK$1 billion corporate venture fund. "We are delighted to host Dalton Venture's CEO Summit and look forward to deepening collaboration with visionary enterprises."
Capital Empowering Innovation: Insights from HKEX
Sam S.K. Luk, Vice President (Global Issuer Services) at Hong Kong Exchanges and Clearing Limited (HKEX), outlined Hong Kong's latest initiatives to support biotech and hard-tech enterprises through listing mechanisms like Chapter 18A and 18C. He emphasized that Hong Kong remains a preferred destination for innovative companies seeking global investors, citing recent resilience in the local stock market and continued inflows from Southbound trading under the Stock Connect program.
Thought Leadership on Frontier Technologies
The summit also featured keynote speeches from leading scientists and entrepreneurs.
Professor Lam Hon Ming, Distinguished Professor of Life Sciences at The Chinese University of Hong Kong, and Director of the State Key Laboratory of Agrobiotechnology shared insights on agricultural biotechnology and sustainability.
Professor Sirui Han, representing Professor Guo Yike, Chief Vice President of the Hong Kong University of Science and Technology and Director of the Hong Kong Center for Generative Artificial Intelligence Research and Development, discussed the evolution of large AI models and their transformative impact on life sciences.
Strengthening Cross-Border Innovation Bridges
Prior to the summit, Dalton Venture organized a closed-door dialogue with InvestHK and the Office for Attracting Strategic Enterprises (OASES), connecting over 30 Mainland biotech companies with Hong Kong's innovation and policy resources. Discussions focused on leveraging Hong Kong as a springboard for global clinical development, regulatory pathways, and international fundraising.
Looking Ahead: Building a Global Innovation Network
Mr. Huang Ning, Founding Partner of Dalton Venture, concluded the summit by reaffirming Dalton's commitment to empowering entrepreneurs and accelerating the globalization of life sciences innovation.
As innovation continues to reshape the life sciences sector, Dalton Venture remains dedicated to fostering a robust, interconnected ecosystem that links research, capital, and industry across borders — advancing healthcare for a better future.
CONTACT
Name: Lynn Ning
Email: ningx@daltonventure.cn
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
AI Evolution and Life Sciences: Embracing New Frontiers at Dalton Venture CEO Summit 2025
HONG KONG, March 13, 2026 /PRNewswire/ -- LiberNovo proudly announces that the LiberNovo Omni has been awarded the iF DESIGN AWARD 2026 in the Product Design – Beauty/Wellness category. The chair represents LiberNovo's breakthrough approach to Dynamic Ergonomics. The iF DESIGN AWARD is widely regarded as one of the most respected awards in international design and recognizes innovative, functional, and user-centric designs.
Revolutionizing Ergonomics
The LiberNovo Omni was designed to revolutionize how people sit during long work hours. Unlike other office chairs that force people into unnatural positions and postures, the LiberNovo Omni introduces a new category of seating, the Dynamic Ergonomic Chair.
The chair supports your body as you naturally move throughout the day, so you can always adjust your position freely and still receive continuous support.
The LiberNovo Omni solves one of the biggest problems facing today's work environment. As work has become more and more desk-based, people are spending more time than ever before sitting. Traditional office chairs are designed for stationary use and often don't accommodate body movement, leading to lower back discomfort and strain.
Technologies Behind the Award-Winning Design
At the core of the LiberNovo Omni's design is Dynamic Support, LiberNovo's adaptive support system that automatically adjusts to posture changes in real time. Instead of requiring users to manually readjust their chairs throughout the day, Dynamic Support continuously responds to body movement, helping maintain balance and ergonomic alignment without interruption.
The chair also features LiberNovo's Bionic FlexFit Backrest, an advanced ergonomic structure that contours to the natural curvature of the spine. Using multiple pivot points and adaptive panels, the backrest distributes pressure evenly across the back while allowing natural motion. This approach provides consistent support from the hips through the shoulders, creating a seating experience that adapts to the individual rather than forcing the individual to adapt to the chair.
The LiberNovo Omni also incorporates multiple recline modes, allowing users to shift naturally between focused work and more relaxed postures while maintaining continuous ergonomic support. For deeper recovery, the chair includes OmniStretch, a guided decompression feature that gently stretches the lower spine and helps relieve pressure accumulated during prolonged sitting.
Together, these technologies define a new approach to ergonomic seating built around movement, adaptability, and long-term physical support.
Design Philosophy
The development of the LiberNovo Omni focused on solving a longstanding challenge in chair design: balancing softness, structural support, and freedom of movement. Traditionally, improving one of these qualities has meant compromising another. The LiberNovo Omni was engineered to bring these elements together in a single system, combining comfort, stability, and natural mobility.
This approach reflects LiberNovo's broader philosophy: the tools we use every day should work with the human body rather than against it. In modern work environments, productivity should not come at the expense of long-term health.
Design Collaboration
The chair was developed by the LiberNovo design team in Shenzhen, China, in collaboration with Kairos Innovation, an industrial design firm based there. Together, the teams focused on creating an ergonomic system that maintains support across the wide range of positions people naturally adopt while working throughout the day.
About the iF DESIGN AWARD
Established in 1954, the iF DESIGN AWARD is an internationally recognized standard for measuring design quality. Entries are selected using strict evaluation criteria, including innovation, functionality, ergonomics, and overall design impact.
In 2026, over 10,000 entries from more than 60 countries were submitted for consideration for the iF DESIGN AWARD. All entries were evaluated by an independent group of international design professionals, making the iF DESIGN AWARD one of the most highly respected design awards available today.
Looking Ahead
Receiving the iF DESIGN AWARD is a significant milestone for LiberNovo, demonstrating the company's continued commitment to advancing ergonomic seating design.
The iF DESIGN AWARD highlights the increasing importance of designing workplace solutions that enable workers to be productive and support their long-term physical health and wellness.
As workspaces continue to evolve, LiberNovo believes seating should move away from static support systems toward more dynamic, human-centered designs.
The LiberNovo Omni embodies this vision by shifting ergonomic design away from static seating, creating a chair that adapts to the user rather than requiring the user to adapt to the chair.
About LiberNovo
LiberNovo is a design and technology company focused on advancing ergonomic innovation for modern work environments. Through a combination of advanced engineering and human-centered design, the company develops intelligent products that respond to the evolving ways people work and interact with their surroundings.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
LiberNovo Omni Wins iF DESIGN AWARD 2026 for Breakthrough Ergonomic Design
